Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Proton MRS of cervical cancer at 7 T.

Arteaga de Castro CS, Hoogendam JP, van Kalleveen IML, Raaijmakers AJE, Zweemer RP, Verheijen RHM, Luijten PR, Veldhuis WB, Klomp DWJ.

NMR Biomed. 2019 Jan;32(1):e4015. doi: 10.1002/nbm.4015. Epub 2018 Oct 30.

PMID:
30376201
2.

Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary care.

Helsper CW, Van Vliet LM, Velthuizen ME, de Wit NJ, Beijaert RP, Butter E, van Gent-Wagemakers MP, Witteveen EO, Zweemer RP, van Dulmen SM, Ausems MG.

Br J Gen Pract. 2018 Nov;68(676):e750-e756. doi: 10.3399/bjgp18X699533.

3.

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.

Roze JF, Hoogendam JP, van de Wetering FT, Spijker R, Verleye L, Vlayen J, Veldhuis WB, Scholten RJ, Zweemer RP.

Cochrane Database Syst Rev. 2018 Oct 8;10:CD012567. doi: 10.1002/14651858.CD012567.pub2.

PMID:
30298516
4.

Characteristics of Lynch syndrome associated ovarian cancer.

Woolderink JM, De Bock GH, de Hullu JA, Hollema H, Zweemer RP, Slangen BFM, Gaarenstroom KN, van Beurden M, van Doorn HC, Sijmons RH, Vasen HFA, Mourits MJE.

Gynecol Oncol. 2018 Aug;150(2):324-330. doi: 10.1016/j.ygyno.2018.03.060. Epub 2018 Jun 5.

PMID:
29880284
5.

Boosting the SNR by adding a receive-only endorectal monopole to an external antenna array for high-resolution, T2 -weighted imaging of early-stage cervical cancer with 7-T MRI.

van Kalleveen IML, Hoogendam JP, Raaijmakers AJE, Visser F, Arteaga de Castro CS, Verheijen RHM, Luijten PR, Zweemer RP, Veldhuis WB, Klomp DWJ.

NMR Biomed. 2017 Sep;30(9). doi: 10.1002/nbm.3750. Epub 2017 Jun 2.

PMID:
28574604
6.

Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.

Cuppens T, Annibali D, Coosemans A, Trovik J, Ter Haar N, Colas E, Garcia-Jimenez A, Van de Vijver K, Kruitwagen RP, Brinkhuis M, Zikan M, Dundr P, Huvila J, Carpén O, Haybaeck J, Moinfar F, Salvesen HB, Stukan M, Mestdagh C, Zweemer RP, Massuger LF, Mallmann MR, Wardelmann E, Mints M, Verbist G, Thomas D, Gommé E, Hermans E, Moerman P, Bosse T, Amant F.

Clin Cancer Res. 2017 Mar 1;23(5):1274-1285. doi: 10.1158/1078-0432.CCR-16-2149.

7.

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.

Zaaijer LH, van Doorn HC, Mourits MJ, van Beurden M, de Hullu JA, Adank MA, van Lonkhuijzen LR, Vasen HF, Slangen BF, Gaarenstroom KN, Zweemer RP, Vencken PM, Seynaeve C, Kriege M.

Br J Cancer. 2016 Nov 8;115(10):1174-1178. doi: 10.1038/bjc.2016.333. Epub 2016 Oct 18.

8.

Vaginal Radical Trachelectomy for Early-Stage Cervical Cancer: Increased Recurrence Risk for Adenocarcinoma.

Zusterzeel PL, Pol FJ, van Ham M, Zweemer RP, Bekkers RL, Massuger LF, Verheijen RH.

Int J Gynecol Cancer. 2016 Sep;26(7):1293-9. doi: 10.1097/IGC.0000000000000763.

PMID:
27643652
9.

Surgical lymph node assessment in mucinous ovarian carcinoma staging: a systematic review and meta-analysis.

Hoogendam JP, Vlek CA, Witteveen PO, Verheijen R, Zweemer RP.

BJOG. 2017 Feb;124(3):370-378. doi: 10.1111/1471-0528.14226. Epub 2016 Jul 22. Review.

10.

High-resolution T2-weighted cervical cancer imaging: a feasibility study on ultra-high-field 7.0-T MRI with an endorectal monopole antenna.

Hoogendam JP, Kalleveen IM, de Castro CS, Raaijmakers AJ, Verheijen RH, van den Bosch MA, Klomp DW, Zweemer RP, Veldhuis WB.

Eur Radiol. 2017 Mar;27(3):938-945. doi: 10.1007/s00330-016-4419-y. Epub 2016 May 31.

11.

Screening to improve ovarian cancer prognosis?

Verheijen RHM, Zweemer RP.

Lancet. 2016 Mar 5;387(10022):921-923. doi: 10.1016/S0140-6736(15)01236-2. Epub 2015 Dec 17. No abstract available.

PMID:
26707055
12.

99mTc-Nanocolloid SPECT/MRI Fusion for the Selective Assessment of Nonenlarged Sentinel Lymph Nodes in Patients with Early-Stage Cervical Cancer.

Hoogendam JP, Zweemer RP, Hobbelink MG, van den Bosch MA, Verheijen RH, Veldhuis WB.

J Nucl Med. 2016 Apr;57(4):551-6. doi: 10.2967/jnumed.115.164780. Epub 2015 Dec 17.

13.

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.

Harmsen MG, Arts-de Jong M, Hoogerbrugge N, Maas AH, Prins JB, Bulten J, Teerenstra S, Adang EM, Piek JM, van Doorn HC, van Beurden M, Mourits MJ, Zweemer RP, Gaarenstroom KN, Slangen BF, Vos MC, van Lonkhuijzen LR, Massuger LF, Hermens RP, de Hullu JA.

BMC Cancer. 2015 Aug 19;15:593. doi: 10.1186/s12885-015-1597-y.

14.

The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.

van der Aa JE, Hoogendam JP, Butter ES, Ausems MG, Verheijen RH, Zweemer RP.

Fam Cancer. 2015 Dec;14(4):539-44. doi: 10.1007/s10689-015-9827-7.

15.

No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer Patients.

Hoogendam JP, Zweemer RP, Verkooijen HM, de Jong PA, van den Bosch MA, Verheijen RH, Veldhuis WB.

PLoS One. 2015 Jul 2;10(7):e0131899. doi: 10.1371/journal.pone.0131899. eCollection 2015.

16.

The diagnostic process of cervical cancer; areas of good practice, and windows of opportunity.

Zaal A, de Wilde MA, Duk MJ, Graziosi GC, van Haaften M, von Mensdorff-Pouilly S, van Diest PJ, Zweemer RP, Peeters PH, Verheijen RH.

Gynecol Oncol. 2015 Aug;138(2):405-10. doi: 10.1016/j.ygyno.2015.05.037. Epub 2015 May 30.

PMID:
26037902
17.

99mTc SPECT/CT Versus Planar Lymphoscintigraphy for Preoperative Sentinel Lymph Node Detection in Cervical Cancer: A Systematic Review and Metaanalysis.

Hoogendam JP, Veldhuis WB, Hobbelink MG, Verheijen RH, van den Bosch MA, Zweemer RP.

J Nucl Med. 2015 May;56(5):675-80. doi: 10.2967/jnumed.114.152439. Epub 2015 Apr 9. Review.

18.

Oncological outcome and long-term complications in robot-assisted radical surgery for early stage cervical cancer: an observational cohort study.

Hoogendam JP, Verheijen RH, Wegner I, Zweemer RP.

BJOG. 2014 Nov;121(12):1538-45. doi: 10.1111/1471-0528.12822. Epub 2014 Apr 16.

19.

Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: a retrospective multicenter cohort study.

Zaal A, Zweemer RP, Zikán M, Dusek L, Querleu D, Lécuru F, Bats AS, Jach R, Sevcik L, Graf P, Klát J, Dyduch G, von Mensdorff-Pouilly S, Kenter GG, Verheijen RH, Cibula D.

Int J Gynecol Cancer. 2014 Feb;24(2):303-11. doi: 10.1097/IGC.0000000000000043.

PMID:
24407577
20.

Genomic and transcriptomic plasticity in treatment-naive ovarian cancer.

Hoogstraat M, de Pagter MS, Cirkel GA, van Roosmalen MJ, Harkins TT, Duran K, Kreeftmeijer J, Renkens I, Witteveen PO, Lee CC, Nijman IJ, Guy T, van 't Slot R, Jonges TN, Lolkema MP, Koudijs MJ, Zweemer RP, Voest EE, Cuppen E, Kloosterman WP.

Genome Res. 2014 Feb;24(2):200-11. doi: 10.1101/gr.161026.113. Epub 2013 Nov 12.

21.

Detection of cervical cancer recurrence during follow-up: a multivariable comparison of 9 frequently investigated serum biomarkers.

Hoogendam JP, Zaal A, Rutten EG, Heijnen CJ, Kenter GG, Veldhuis WB, Verheijen RH, Zweemer RP.

Gynecol Oncol. 2013 Dec;131(3):655-60. doi: 10.1016/j.ygyno.2013.10.016. Epub 2013 Oct 22.

PMID:
24157617
22.

CT, MRI and laparoscopy findings of a retroperitoneally herniated ovary causing acute abdominal pain.

Hoogendam JP, Zweemer RP, Schaap TP, Schreuder HW, Veldhuis WB.

Hernia. 2014;18(6):915-7. doi: 10.1007/s10029-013-1139-y. Epub 2013 Jul 19.

PMID:
23868352
23.

Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis.

Bijron JG, Seldenrijk CA, Zweemer RP, Lange JG, Verheijen RH, van Diest PJ.

Am J Surg Pathol. 2013 Aug;37(8):1123-30. doi: 10.1097/PAS.0b013e318282da7f.

PMID:
23648462
24.

Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands.

Vencken PM, Reitsma W, Kriege M, Mourits MJ, de Bock GH, de Hullu JA, van Altena AM, Gaarenstroom KN, Vasen HF, Adank MA, Schmidt MK, van Beurden M, Zweemer RP, Rijcken F, Slangen BF, Burger CW, Seynaeve C.

Ann Oncol. 2013 Aug;24(8):2036-42. doi: 10.1093/annonc/mdt068. Epub 2013 Mar 29.

PMID:
23543211
25.

Preoperative sentinel node mapping with (99m)Tc-nanocolloid SPECT-CT significantly reduces the intraoperative sentinel node retrieval time in robot assisted laparoscopic cervical cancer surgery.

Hoogendam JP, Hobbelink MG, Veldhuis WB, Verheijen RH, van Diest PJ, Zweemer RP.

Gynecol Oncol. 2013 May;129(2):389-94. doi: 10.1016/j.ygyno.2013.02.020. Epub 2013 Feb 21.

PMID:
23454644
26.

Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis.

Cibula D, Abu-Rustum NR, Dusek L, Slama J, Zikán M, Zaal A, Sevcik L, Kenter G, Querleu D, Jach R, Bats AS, Dyduch G, Graf P, Klat J, Meijer CJ, Mery E, Verheijen R, Zweemer RP.

Gynecol Oncol. 2012 Dec;127(3):462-6. doi: 10.1016/j.ygyno.2012.08.035. Epub 2012 Aug 31.

PMID:
22943880
27.

Genomic aberrations relate early and advanced stage ovarian cancer.

Zaal A, Peyrot WJ, Berns PM, van der Burg ME, Veerbeek JH, Trimbos JB, Cadron I, van Diest PJ, van Wieringen WN, Krijgsman O, Meijer GA, Piek JM, Timmers PJ, Vergote I, Verheijen RH, Ylstra B, Zweemer RP; EORTC GCG Translational Research Group.

Cell Oncol (Dordr). 2012 Jun;35(3):181-8. doi: 10.1007/s13402-012-0077-5. Epub 2012 May 12.

28.

Increasing experience in laparoscopic staging of early ovarian cancer.

Schreuder HW, Pattij TO, Zweemer RP, van Baal MW, Verheijen RH.

Gynecol Surg. 2012 Feb;9(1):89-96. Epub 2011 Jul 14.

29.

Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer.

Cibula D, Abu-Rustum NR, Dusek L, Zikán M, Zaal A, Sevcik L, Kenter GG, Querleu D, Jach R, Bats AS, Dyduch G, Graf P, Klat J, Lacheta J, Meijer CJ, Mery E, Verheijen R, Zweemer RP.

Gynecol Oncol. 2012 Mar;124(3):496-501. doi: 10.1016/j.ygyno.2011.11.037. Epub 2011 Nov 25.

PMID:
22120175
30.

Training and learning robotic surgery, time for a more structured approach: a systematic review.

Schreuder HW, Wolswijk R, Zweemer RP, Schijven MP, Verheijen RH.

BJOG. 2012 Jan;119(2):137-49. doi: 10.1111/j.1471-0528.2011.03139.x. Epub 2011 Oct 10. Review.

31.

From open radical hysterectomy to robot-assisted laparoscopic radical hysterectomy for early stage cervical cancer: aspects of a single institution learning curve.

Schreuder HW, Zweemer RP, van Baal WM, van de Lande J, Dijkstra JC, Verheijen RH.

Gynecol Surg. 2010 Sep;7(3):253-258. Epub 2010 Apr 13.

32.

The influence of the b-value combination on apparent diffusion coefficient based differentiation between malignant and benign tissue in cervical cancer.

Hoogendam JP, Klerkx WM, de Kort GA, Bipat S, Zweemer RP, Sie-Go DM, Verheijen RH, Mali WP, Veldhuis WB.

J Magn Reson Imaging. 2010 Aug;32(2):376-82. doi: 10.1002/jmri.22236.

PMID:
20677265
33.

Methylation profiles of endometrioid and serous endometrial cancers.

Seeber LM, Zweemer RP, Marchionni L, Massuger LF, Smit VT, van Baal WM, Verheijen RH, van Diest PJ.

Endocr Relat Cancer. 2010 Jun 25;17(3):663-73. doi: 10.1677/ERC-10-0014. Print 2010 Sep.

PMID:
20488783
34.

Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management.

Seeber LM, Zweemer RP, Verheijen RH, van Diest PJ.

Obstet Gynecol Int. 2010;2010:580971. doi: 10.1155/2010/580971. Epub 2010 Feb 14.

35.

Ovarian carcinogenesis, an alternative theory.

Piek JM, Kenemans P, Zweemer RP, van Diest PJ, Verheijen RH.

Gynecol Oncol. 2007 Nov;107(2):355. Epub 2007 Aug 9. No abstract available.

PMID:
17692366
36.

A case of loss of heterozygosity in the BRCA2 gene of a borderline ovarian tumor: case report and review of literature.

Verbruggen MB, Zweemer RP, Piek JM, van Unnik GA, van Diest PJ, Gille JJ, Menko FH, Dorsman JC, Verheijen RH.

Int J Gynecol Cancer. 2007 Sep-Oct;17(5):1143-7. Epub 2007 Mar 26. Review.

PMID:
17386038
37.

Epithelioid trophoblastic tumour: a case report and review of the literature.

Vencken PM, Ewing PC, Zweemer RP.

J Clin Pathol. 2006 Dec;59(12):1307-8. Review.

38.

Comment on Elit et al.: prophylactic oophorectomy in Ontario.

Zweemer RP, Jacobs IJ.

Fam Cancer. 2001;1(3-4):187-8. No abstract available.

PMID:
14574177
39.

Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study.

Piek JM, Torrenga B, Hermsen B, Verheijen RH, Zweemer RP, Gille JJ, Kenemans P, van Diest PJ, Menko FH.

Fam Cancer. 2003;2(2):73-8.

PMID:
14574155
40.

Women harboring BRCA1/2 germline mutations are at risk for breast and female adnexal carcinoma.

Piek JM, Dorsman JC, Zweemer RP, Verheijen RH, van Diest PJ, Colgan TJ.

Int J Gynecol Pathol. 2003 Jul;22(3):315-6; author reply 315-6. No abstract available.

PMID:
12819403
41.

Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.

Jongsma AP, Piek JM, Zweemer RP, Verheijen RH, Klein Gebbinck JW, van Kamp GJ, Jacobs IJ, Shaw P, van Diest PJ, Kenemans P.

Mol Pathol. 2002 Oct;55(5):305-9.

42.

Histopathologic features of genetically determined ovarian cancer.

Shaw PA, McLaughlin JR, Zweemer RP, Narod SA, Risch H, Verheijen RH, Ryan A, Menko FH, Kenemans P, Jacobs IJ.

Int J Gynecol Pathol. 2002 Oct;21(4):407-11.

PMID:
12352190
43.

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, Gille JJ, Jongsma AP, Pals G, Kenemans P, Verheijen RH.

J Pathol. 2001 Nov;195(4):451-6.

PMID:
11745677
44.

Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma.

Zweemer RP, Ryan A, Snijders AM, Hermsen MA, Meijer GA, Beller U, Menko FH, Jacobs IJ, Baak JP, Verheijen RH, Kenemans P, van Diest PJ.

Lab Invest. 2001 Oct;81(10):1363-70.

PMID:
11598149
45.

Survival analysis in familial ovarian cancer, a case control study.

Zweemer RP, Verheijen RH, Coebergh JW, Jacobs IJ, van Diest PJ, Gille JJ, Skates S, Menko FH, Ten Kate LP, Kenemans P.

Eur J Obstet Gynecol Reprod Biol. 2001 Oct;98(2):219-23.

PMID:
11574135
46.

Tubal ligation and risk of ovarian cancer.

Piek JM, van Diest PJ, Zweemer RP, Kenemans P, Verheijen RH.

Lancet. 2001 Sep 8;358(9284):844. No abstract available.

PMID:
11570411
47.

Familial ovarian cancer.

Zweemer RP, Jacobs IJ.

Methods Mol Med. 2001;39:13-24. doi: 10.1385/1-59259-071-3:13.

PMID:
21340754
48.

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.

Zweemer RP, van Diest PJ, Verheijen RH, Ryan A, Gille JJ, Sijmons RH, Jacobs IJ, Menko FH, Kenemans P.

Gynecol Oncol. 2000 Jan;76(1):45-50.

PMID:
10620440
49.

Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.

Zweemer RP, Shaw PA, Verheijen RM, Ryan A, Berchuck A, Ponder BA, Risch H, McLaughlin JR, Narod SA, Menko FH, Kenemans P, Jacobs IJ.

J Clin Pathol. 1999 May;52(5):372-5.

50.

Differences between hereditary and sporadic ovarian cancer.

Zweemer RP, Verheijen RH, Menko FH, Gille JJ, van Diest PJ, Coebergh JW, Shaw PA, Jacobs IJ, Kenemans P.

Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):151-3.

PMID:
10206407

Supplemental Content

Loading ...
Support Center